ZA835009B - Heterocyclic derivatives - Google Patents

Heterocyclic derivatives

Info

Publication number
ZA835009B
ZA835009B ZA835009A ZA835009A ZA835009B ZA 835009 B ZA835009 B ZA 835009B ZA 835009 A ZA835009 A ZA 835009A ZA 835009 A ZA835009 A ZA 835009A ZA 835009 B ZA835009 B ZA 835009B
Authority
ZA
South Africa
Prior art keywords
heterocyclic derivatives
heterocyclic
derivatives
Prior art date
Application number
ZA835009A
Other languages
English (en)
Inventor
Barry John Price
Roger Hayes
David Edmund Bays
John Wilson Macfarla Mackinnon
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of ZA835009B publication Critical patent/ZA835009B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D285/00Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01Five-membered rings
    • C07D285/02Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/101,2,5-Thiadiazoles; Hydrogenated 1,2,5-thiadiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/28Radicals substituted by nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
ZA835009A 1982-07-08 1983-07-08 Heterocyclic derivatives ZA835009B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8219746 1982-07-08

Publications (1)

Publication Number Publication Date
ZA835009B true ZA835009B (en) 1985-02-27

Family

ID=10531541

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA835009A ZA835009B (en) 1982-07-08 1983-07-08 Heterocyclic derivatives

Country Status (11)

Country Link
JP (1) JPS5927880A (xx)
AU (1) AU1666583A (xx)
BE (1) BE897247A (xx)
DE (1) DE3324771A1 (xx)
DK (1) DK317283A (xx)
FR (1) FR2532937A1 (xx)
GB (1) GB2124622A (xx)
IT (1) IT8348653A0 (xx)
NL (1) NL8302450A (xx)
SE (1) SE8303913L (xx)
ZA (1) ZA835009B (xx)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4567191A (en) * 1983-06-07 1986-01-28 Merck & Co., Inc. Amino-phenyl-thiadiazoledioxides as gastric secretion inhibitors
DE3326545A1 (de) * 1983-07-22 1985-01-31 Ludwig Heumann & Co GmbH, 8500 Nürnberg Propan-2-ol-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE3408327A1 (de) * 1984-03-07 1985-09-12 Ludwig Heumann & Co GmbH, 8500 Nürnberg Diaminderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
CN1720240B (zh) 2002-10-09 2010-10-27 先灵公司 作为cxc-和cc-趋化因子受体配体的噻二唑二氧化物和噻二唑氧化物
CN1918138B (zh) 2003-12-19 2011-05-04 先灵公司 作为cxc-和cc-趋化因子受体配体的噻二唑化合物
MXPA06007205A (es) 2003-12-22 2006-08-31 Schering Corp Dioxidos de isotiazol como ligandos del receptor cxc y cc-quimiocina.
JP2009500334A (ja) 2005-06-29 2009-01-08 シェーリング コーポレイション Cxc−ケモカインレセプターリガンドとしてのジ置換オキサジアゾール
EP1907399B1 (en) 2005-06-29 2010-10-27 Schering Corporation 5,6-di-substituted oxadiazolopyrazines and thiadiazolopyrazines as cxc-chemokine receptor ligands
EP4196793A1 (en) 2020-08-11 2023-06-21 Université de Strasbourg H2 blockers targeting liver macrophages for the prevention and treatment of liver disease and cancer

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0040696B1 (en) * 1980-04-30 1986-08-27 Merck & Co. Inc. Aminothiadiazoles as gastric secretion inhibitors
US4411899A (en) * 1981-12-21 1983-10-25 Merck & Co., Inc. Substituted derivatives of amino alkane diols as gastric secretion inhibitors

Also Published As

Publication number Publication date
DE3324771A1 (de) 1984-01-12
BE897247A (fr) 1984-01-09
IT8348653A0 (it) 1983-07-08
DK317283D0 (da) 1983-07-08
SE8303913D0 (sv) 1983-07-08
AU1666583A (en) 1984-01-12
DK317283A (da) 1984-01-09
NL8302450A (nl) 1984-02-01
JPS5927880A (ja) 1984-02-14
GB8318525D0 (en) 1983-08-10
SE8303913L (sv) 1984-01-09
FR2532937A1 (fr) 1984-03-16
GB2124622A (en) 1984-02-22

Similar Documents

Publication Publication Date Title
GB2119801B (en) Heterocyclic compounds
GB8315564D0 (en) Heterocyclic compounds
GB8300095D0 (en) Heterocyclic compounds
PT76791A (en) Heterocyclic compounds
DE3274856D1 (en) Heterocyclic derivatives
GB2075007B (en) Heterocyclic derivatives
ZA815964B (en) Heterocyclic derivatives
GB8318525D0 (en) Heterocyclic derivatives
ZA815962B (en) Heterocyclic derivatives
DE3377060D1 (en) Heterocyclic compounds
ZA815961B (en) Heterocyclic derivatives
GB8308866D0 (en) Heterocyclic compounds
ZA834032B (en) Heterocyclic compounds
GB8304744D0 (en) Heterocyclic compounds
ZA831466B (en) Heterocyclic compounds
GB2116178B (en) Heterocyclic derivatives
DE3275291D1 (en) Heterocyclic derivatives
ZA831263B (en) Heterocyclic derivatives
ZA821307B (en) Heterocyclic derivatives
ZA839699B (en) Heterocyclic derivatives
GB8303097D0 (en) Heterocyclic derivatives
ZA834100B (en) Heterocyclic compounds
GB8308171D0 (en) Heterocyclic derivatives
GB8310519D0 (en) Heterocyclic derivatives
GB8329020D0 (en) Heterocyclic derivatives